Monster Beverage
MNST
$44.27
+0.61%
Monster Beverage Corporation is a global leader in the energy drink category within the non-alcoholic ready-to-drink beverage market, generating roughly two-thirds of its revenue from the US and Canada through brands including Monster Energy, Monster Ultra, Java Monster, and Juice Monster, alongside Reign, NOS, Burn, Bang, and Mother, plus a small alcohol portfolio following its 2022 craft brewer acquisition. The company operates an asset-light model, controlling branding and innovation while outsourcing manufacturing to co-packers and distribution to bottlers within the global Coca-Cola system under a 20-year agreement signed in 2015, with Coca-Cola holding a 20% equity stake — a structural advantage that gives Monster unmatched shelf placement and distribution reach relative to independent competitors. The current investor narrative centers on a sharp reacceleration in growth, with Q1 2026 revenue up 26.9% year over year to $2.35 billion and EPS of $0.58, well ahead of the roughly $0.45 reported in the prior-year quarter, alongside a 2-for-1 stock split completed on August 11, 2026 that broadened the shareholder base. Debate among investors now hinges on whether this growth burst is durable — driven by international expansion and pricing — or whether it reflects a one-time pull-forward, particularly as rival Celsius stumbled with an 18% single-day drop on a Q2 miss, raising questions about category-wide demand elasticity and competitive intensity.…
MNST
Monster Beverage
$44.27
Related headlines
Investment Opinion: Should I buy MNST Today?
We assign a Hold rating on Monster Beverage. While the company's Q1 2026 revenue growth of 26.9% and debt-free balance sheet are impressive, the stock's premium valuation (39.3x trailing P/E, 34.2x forward P/E) and recent price weakness (-5.7% over one month) suggest the market has already priced in much of the optimism. The analyst consensus target of $50.24 offers only 12.4% upside, which is not compelling enough to justify a Buy given the sustainability questions around the growth spike.
The supporting evidence for a Hold is balanced: revenue growth is accelerating (26.9% YoY), profitability is strong (net margin 23.0%, ROE 23.1%), and free cash flow is robust at $2.07 billion TTM. However, the valuation multiples are stretched relative to peers and the company's own history, with a PEG ratio of 1.31 suggesting the growth is fairly priced. The lack of dividend and the recent underperformance versus the S&P 500 (-4.8% relative strength over one month) further support a neutral stance.
The biggest risks that could invalidate this thesis include a sharper-than-expected deceleration in revenue growth, competitive share loss to Celsius or others, and multiple compression if interest rates remain elevated. We would upgrade to Buy if the stock pulls back to the $35-38 range (analyst low target) or if Q2 2026 revenue growth exceeds 20% with margin expansion. Conversely, we would downgrade to Sell if revenue growth falls below 10% or if gross margins drop below 50%. At current levels, the stock appears fairly valued to slightly overvalued relative to its growth prospects.
Sign up to view all
MNST 12-Month Price Forecast
Monster Beverage presents a balanced risk/reward profile. The company's strong Q1 2026 results and debt-free balance sheet are offset by a premium valuation and questions about the durability of its growth spike. The analyst community remains constructive with a $50.24 average target, but the stock's recent underperformance and Celsius's stumble suggest caution. We maintain a neutral stance, with a slight tilt toward bearishness if growth decelerates. An upgrade to bullish would require evidence of sustained revenue growth above 20% and margin expansion, while a downgrade to bearish would follow a significant growth miss or competitive share loss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $50.24 and implied upside of +13.5% versus the current price.
Average Target
$50.24
0 analysts
Implied Upside
+13.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$35 - $57
Analyst target range
Bulls vs Bears: MNST Investment Factors
The bull case for Monster Beverage rests on its impressive Q1 2026 revenue acceleration (26.9% YoY), debt-free balance sheet, and the structural moat provided by its Coca-Cola partnership. However, the bear case is equally compelling: a rich valuation (39x trailing P/E), recent price weakness (-5.7% over one month), and signs of category-wide headwinds from Celsius's stumble. Currently, the bear evidence appears slightly stronger due to the stock's premium multiple and the sustainability question surrounding the Q1 growth spike. The single most important tension is whether the 26.9% growth is a durable inflection driven by international expansion and pricing, or a one-time pull-forward that will revert to mid-single-digit growth, which would likely trigger a valuation reset.
Bullish
- Q1 2026 revenue accelerated 26.9% YoY: Monster's Q1 2026 revenue reached $2.353 billion, up 26.9% from $1.855 billion in Q1 2025, marking a sharp reacceleration from the mid-single-digit growth seen in prior quarters. This surge was driven by international expansion and pricing power, with EPS jumping to $0.58 from $0.45 a year earlier.
- Fortress balance sheet with zero debt: The company carries no debt (debt-to-equity of 0) and a current ratio of 3.70, providing immense financial flexibility. This allows Monster to fund growth initiatives, weather downturns, and potentially return capital without balance-sheet stress.
- Analyst consensus sees 12.4% upside: With 23 analysts covering the stock, the average target price is $50.24 versus the current price of $44.71, implying roughly 12.4% upside. The recommendation mean of 2.04 (buy) and high target of $57 suggest continued optimism on the growth trajectory.
- Coca-Cola partnership ensures distribution moat: The 20-year agreement with Coca-Cola (which owns 20% of Monster) gives the company unmatched shelf placement and distribution reach across the global bottler network. This structural advantage is difficult for competitors like Celsius to replicate and supports long-term market share gains.
Bearish
- Valuation is rich at 39x trailing earnings: MNST trades at a trailing P/E of 39.3 and a forward P/E of 34.2, well above the broader consumer staples sector. The price-to-sales ratio of 9.0 and EV/EBITDA of 27.9 imply the market is pricing in sustained high growth, leaving little room for disappointment.
- Recent momentum has stalled: Despite a 38.3% gain over the past year, the stock is down 5.7% in the last month and 2.1% over three months, underperforming the S&P 500 by 4.8 and 4.1 percentage points, respectively. This recent weakness suggests the Q1 growth burst may not be durably accelerating.
- Celsius weakness signals category headwinds: Rival Celsius tumbled 18% in a single day following a Q2 miss and declining flagship sales, raising concerns about demand elasticity and competitive intensity across the energy drink category. If the category leader stumbles, Monster could face similar pressures.
- Growth may be a one-time pull-forward: The 26.9% revenue growth in Q1 2026 could reflect inventory loading or one-time pricing actions rather than sustainable demand. Sequential revenue declined from $2.353 billion in Q1 to $2.131 billion in Q4 2025, highlighting potential seasonality or demand normalization.
MNST Technical Analysis
Beta
0.52
0.52x market volatility
Max Drawdown
-17.7%
Largest decline past year
52-Week Range
$32-$50
Price range past year
Annual Return
+38.4%
Cumulative gain past year
| Period | MNST Return | S&P 500 |
|---|---|---|
| 1m | -7.4% | +1.0% |
| 3m | -6.5% | +5.5% |
| 6m | +23.0% | +19.9% |
| 1y | +38.4% | +16.0% |
| ytd | +16.3% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MNST Fundamental Analysis
Quarterly Revenue
$2.4B
2026-03
Revenue YoY Growth
+26.9%
YoY Comparison
Gross Margin
55.0%
Latest Quarter
Free Cash Flow
$2.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MNST Overvalued?
PE
39.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 30x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.9x
Enterprise Value Multiple
Investment Risk Disclosure
Monster's financial risks are relatively contained given its debt-free balance sheet (debt-to-equity of 0) and strong current ratio of 3.70, but the company's premium valuation (39.3x trailing P/E, 9.0x P/S) leaves it vulnerable to any earnings miss. The Q1 2026 revenue surge to $2.353 billion (up 26.9% YoY) may not be sustainable, and a deceleration could compress the multiple. Additionally, with 100% of revenue from beverages and two-thirds from the US and Canada, geographic concentration adds risk if North American demand softens. The lack of dividend (payout ratio 0) means returns depend entirely on price appreciation, increasing sensitivity to growth expectations.
Market and competitive risks are significant. The energy drink category is intensifying, as evidenced by Celsius's 18% single-day drop on a Q2 miss, which signals potential demand elasticity and competitive pressures. Monster's low beta of 0.515 reduces market correlation but also limits upside in strong markets. The stock's relative strength has deteriorated recently, with a -4.8% underperformance versus the S&P 500 over the past month. Regulatory risks, such as potential labeling or ingredient restrictions, could also impact the category. Furthermore, the high short ratio of 4.15 suggests some investors are betting against the stock, which could amplify volatility.
In a worst-case scenario, a combination of decelerating growth, competitive share loss, and multiple compression could drive the stock toward its 52-week low of $31.51, representing a 29.5% decline from the current price of $44.71. The analyst low target of $35.00 implies a 21.7% downside. If Q2 2026 results show revenue growth falling below 10% and margins contract, the stock could quickly re-rate to a market-average multiple, erasing recent gains. The maximum drawdown over the past year was -17.7%, but a more severe scenario could see losses exceeding 30% if the growth narrative unravels.
FAQ
The key risks include: 1) Valuation risk: the premium multiple (39.3x P/E) could compress if growth slows, leading to a 20-30% downside. 2) Competitive risk: Celsius's 18% single-day drop on a Q2 miss highlights category pressures, and Monster could lose share if it fails to innovate. 3) Concentration risk: two-thirds of revenue comes from the US and Canada, making it vulnerable to regional economic downturns. 4) Execution risk: the Q1 2026 growth spike may not be sustainable, and any miss could trigger a sharp sell-off. These risks are ranked from highest to lowest severity, with valuation and competitive risks being the most immediate.
Our 12-month forecast for MNST includes three scenarios: a base case (55% probability) with a target range of $48-52, assuming revenue growth moderates to 15-18% and margins hold steady; a bull case (25% probability) targeting $55-57, driven by sustained >20% growth and international expansion; and a bear case (20% probability) targeting $35-38, if growth decelerates to single digits and competition intensifies. The most likely scenario is the base case, which aligns with the analyst average target of $50.24. The key assumption is that Monster can maintain double-digit revenue growth without sacrificing margins.
MNST appears slightly overvalued relative to its growth prospects and peers. The trailing P/E of 39.3 and forward P/E of 34.2 are well above the consumer staples sector average, while the PEG ratio of 1.31 suggests the growth is fairly priced but not cheap. The price-to-sales ratio of 9.0 and EV/EBITDA of 27.9 further indicate a premium valuation. The market is pricing in sustained high-teens revenue growth, so any deceleration could lead to multiple compression. Compared to its own history, the stock is trading at the higher end of its range, implying limited upside from multiple expansion.
MNST is a good buy for long-term growth investors who believe in the durability of the energy drink category and Monster's competitive advantages. The stock offers 12.4% upside to the analyst average target of $50.24, but trades at a premium valuation (39.3x trailing P/E) that leaves little room for error. The biggest downside risk is a growth deceleration that could push the stock to the analyst low target of $35, representing a 21.7% decline. Therefore, it is more suitable for investors with a higher risk tolerance and a multi-year horizon, ideally accumulating on dips below $40.
MNST is more suitable for long-term investment (minimum 3-5 years) given its strong brand, competitive moat, and consistent cash flow generation. The stock's low beta (0.515) and lack of dividend make it less appealing for short-term trading or income-focused investors. However, the recent volatility and premium valuation suggest that short-term traders could capitalize on swings, but with higher risk. For long-term holders, the company's growth trajectory and partnership with Coca-Cola provide a solid foundation, but investors should be prepared for periodic drawdowns, as evidenced by the -17.7% max drawdown over the past year. A buy-and-hold strategy with a focus on accumulation during market dislocations is recommended.